Finance

Beta
Lists
002589:SHE
Realcan Pharmaceutical Group Co Ltd
CNÂ¥2.87
+2.14%
(+0.060) 1D
Jun 5, 3:04:45 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002589...
Open
CNÂ¥2.82
High
CNÂ¥2.89
Low
CNÂ¥2.82
Mkt. cap
4.23B
Avg. vol.
40.37M
Volume
25.63M
P/E ratio
350.43
52-wk high
CNÂ¥4.69
52-wk low
CNÂ¥2.77
EPS
CNÂ¥0.01
Shares outstanding
1.50B
No. of employees
2K
Open
CNÂ¥2.82
High
CNÂ¥2.89
Low
CNÂ¥2.82
Mkt. cap
4.23B
Avg. vol.
40.37M
Volume
25.63M
P/E ratio
350.43
52-wk high
CNÂ¥4.69
52-wk low
CNÂ¥2.77
EPS
CNÂ¥0.01
Shares outstanding
1.50B
No. of employees
2K
News stories
From sources across the web
About Realcan Pharmaceutical Group Co Ltd
CEO-
Employees2.41K
FoundedSep 21, 2004
Headquarters-
SectorHealth care provider
Websiterealcan.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.79B
1.86B
1.89B
1.71B
Cost of goods sold
1.66B
1.61B
1.74B
1.49B
Cost of revenue
1.66B
1.61B
1.74B
1.49B
Research and development expenses
8.24M
5.31M
4.40M
2.71M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
159.92M
175.68M
128.25M
144.14M
Operating expense
176.73M
170.72M
175.33M
155.66M
Total operating expenses
1.83B
1.78B
1.92B
1.64B
Operating income
-45.76M
79.41M
-29.77M
62.58M
Other non operating income
27.95M
-43.53M
-34.43M
-2.05M
EBT including unusual items
-38.78M
19.93M
-1.86M
16.32M
EBT excluding unusual items
-42.61M
22.05M
-2.72M
16.16M
Income tax expense
-49.95M
23.53M
-18.76M
697.10K
Effective tax rate
128.80%
118.07%
1,009.59%
4.27%
Other operating expenses
6.21M
12.43M
8.46M
8.65M
Net income
4.00M
-6.03M
3.93M
10.37M
Net profit margin
0.22%
-0.32%
0.21%
0.61%
Earnings per share
-
-
-
-
Interest and investment income
17.56M
25.13M
83.49M
10.96M
Interest expense
-42.35M
-38.96M
-22.01M
-55.32M
Net interest expenses
-24.79M
-13.83M
61.48M
-44.36M
Depreciation and amortization charges
-
-
-
-
EBITDA
-9.43M
119.81M
7.54M
99.89M
Gain or loss from assets sale
-173.18K
173.18K
-1.82M
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more